pipette
ENEnglish

Antibody full-length light chain reshapes variable domains aggregation without altering their dominance in amyloid fibrils

B. Patel, S. Palkar, A. Kumawat, A. Ghosh, S. Singh, T. Aggarwal, S. Pradhan, S. Syam, S. G. Nathan, J. Singh, S. Puri

PreprintAfirmaciones fuertes, leer con cuidadoUso en el mundo real

En palabras de los autores

AL amyloidosis is a fatal systemic amyloid disease in which antibody light chains (LCs), including full-length (FL) and their proteolytically fragmented variable (VL) and constant (CL) domains, aggregate within a complex extracellular matrix (ECM) across multiple tissues. However, how these co-existing species shape aggregation kinetics, fibril morphology, stability, and toxicity remains unexplored. In this work, using a patient-derived LC (AL55), we show that FL transiently interacts with VL, slowing its aggregation nearly four-fold and diverting it into protease-sensitive, seeding-incompetent protofibrillar aggregates rather than mature amyloid assemblies. VL alone or in the presence of inert CL instead matures into toxic, protease-resistant, seeding-competent helical fibrils. Owing to their greater protease resistance and seeding competence, VL-dominated amyloid assemblies persist and contribute to their enrichment within tissues. The FL-mediated redirection is generic across multiple amyloidogenic VLs. These results reveal that LC aggregation, like that of A{beta} and Tau, is governed by interplay between full-length and fragmented species, rather than VL domain aggregation in isolation. Overall, this work identifies a molecular basis for the selective enrichment of VL fibrils in patients and provides a therapeutic rationale for stabilizing VL domains to prevent their pathological aggregation.

Resultado principalEl resumen no menciona limitaciones.

Apareció: miércoles, 18 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.11.16.766878